Blockade of brain dopamine receptors antagonizes the anti-immobility effect of MIF-1 and Tyr-MIF-1 in rats

This publication has 27 references indexed in Scilit:

• Existence of antiopiate systems as illustrated by MIF-1/Tyr-MIF-1
  Life Sciences, 1986
• Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioural ‘despair’ test in rats
  European Journal of Pharmacology, 1985
• Mesolimbic and striatal dopamine receptor supersensitivity: Prophylactic and reversal effects of L-prolyl-L-leucyl-glycinamide (PLG)
  Peptides, 1985
• Repeated treatment with amitriptyline reduces immobility in the behavioural ‘despair’ test in rats by activating dopaminergic and β-adrenergic mechanisms
  Journal of Pharmacy and Pharmacology, 1985
• Effect of repeated treatment with desipramine in the behavioral “despair” test in rats: Antagonism by “atypical” but not “classical” neuroleptics or antiadrenergic drugs
  Life Sciences, 1984
• Immobility test: effects of 5-hydroxytryptaminergic drugs and role of catecholamines in the activity of some antidepressants
  Journal of Pharmacy and Pharmacology, 1981
• The effects of a hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the rat
  Life Sciences, 1981
• Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-I) in depression
  American Journal of Psychiatry, 1978
• POTENTIATION OF LEVODOPA EFFECT BY INTRAVENOUS L-PROLYL-L-LEUCYL-GLYCINE AMIDE IN MAN
  The Lancet, 1975
• Melanocyte-Stimulating Hormone-Release Inhibiting Hormone as an Antidepressant
  Archives of General Psychiatry, 1974